![Lisa A. Michaels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Lisa A. Michaels worked as the Head of Rare Disease, Cell & Gene Therapy at Bayer Pharmaceuticals Corp.
She then worked as the Chief Medical Officer & Executive Vice President at Editas Medicine, Inc. from 2020 to 2022.
Michaels holds a doctorate degree from the University of Virginia.
Anciens postes connus de Lisa A. Michaels
| Sociétés | Poste | Fin |
|---|---|---|
| EDITAS MEDICINE, INC. | Directeur Technique/Scientifique/R&D | 07/02/2022 |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | 01/11/2020 |
Formation de Lisa A. Michaels
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
12
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Bayer Pharmaceuticals Corp. | |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
